These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
383 related items for PubMed ID: 26040705
1. Sirolimus for the treatment of children with various complicated vascular anomalies. Lackner H, Karastaneva A, Schwinger W, Benesch M, Sovinz P, Seidel M, Sperl D, Lanz S, Haxhija E, Reiterer F, Sorantin E, Urban CE. Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705 [Abstract] [Full Text] [Related]
2. Sirolimus in the Treatment of Vascular Anomalies. Triana P, Dore M, Cerezo VN, Cervantes M, Sánchez AV, Ferrero MM, González MD, Lopez-Gutierrez JC. Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921 [Abstract] [Full Text] [Related]
4. Sirolimus for the treatment of complicated vascular anomalies in children. Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Pediatr Blood Cancer; 2011 Dec 01; 57(6):1018-24. PubMed ID: 21445948 [Abstract] [Full Text] [Related]
5. [Our experience with sirolimus for the treatment of complicated vascular anomalies]. Giménez-Aleixandre C, Méndez-Aguirre NA, Martínez-Menchón T, Girón Vallejo Ó, Fernández-Ibieta M, Ferri-Ñíguez B, Villamil V, Sánchez-Sánchez Á, Montoya-Rangel CA, Hernández-Bermejo JP. Cir Pediatr; 2019 Jan 21; 32(1):28-33. PubMed ID: 30714698 [Abstract] [Full Text] [Related]
6. Vascular Anomalies: Diagnosis of Complicated Anomalies and New Medical Treatment Options. Adams DM, Ricci KW. Hematol Oncol Clin North Am; 2019 Jun 21; 33(3):455-470. PubMed ID: 31030813 [Abstract] [Full Text] [Related]
7. Severe adverse events during sirolimus "off-label" therapy for vascular anomalies. Rössler J, Baselga E, Davila V, Celis V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM, Kapp FG. Pediatr Blood Cancer; 2021 Aug 21; 68(8):e28936. PubMed ID: 33580918 [Abstract] [Full Text] [Related]
10. Sirolimus for the Treatment of a Massive Capillary-Lymphatico-Venous Malformation: A Case Report. Vlahovic AM, Vlahovic NS, Haxhija EQ. Pediatrics; 2015 Aug 21; 136(2):e513-6. PubMed ID: 26148957 [Abstract] [Full Text] [Related]
11. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series. Le Sage S, David M, Dubois J, Powell J, McCuaig CC, Théorêt Y, Kleiber N. Pediatr Dermatol; 2018 Jul 21; 35(4):472-477. PubMed ID: 29790593 [Abstract] [Full Text] [Related]
12. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review. Freixo C, Ferreira V, Martins J, Almeida R, Caldeira D, Rosa M, Costa J, Ferreira J. J Vasc Surg; 2020 Jan 21; 71(1):318-327. PubMed ID: 31676179 [Abstract] [Full Text] [Related]
13. Single-center experience with sirolimus therapy for vascular malformations. Yesil S, Tanyildiz HG, Bozkurt C, Cakmakci E, Sahin G. Pediatr Hematol Oncol; 2016 Apr 21; 33(3):219-25. PubMed ID: 27128161 [Abstract] [Full Text] [Related]
14. Efficacy of sirolimus in children with lymphatic malformations of the head and neck. Wiegand S, Dietz A, Wichmann G. Eur Arch Otorhinolaryngol; 2022 Aug 21; 279(8):3801-3810. PubMed ID: 35526176 [Abstract] [Full Text] [Related]
15. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations. Triana P, Miguel M, Díaz M, Cabrera M, López Gutiérrez JC. Lymphat Res Biol; 2019 Oct 21; 17(5):504-511. PubMed ID: 30985248 [Abstract] [Full Text] [Related]
16. Medical management of vascular anomalies. Trenor CC. Semin Cutan Med Surg; 2016 Sep 21; 35(3):177-81. PubMed ID: 27607327 [Abstract] [Full Text] [Related]
17. Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants. Czechowicz JA, Long-Boyle JR, Rosbe KW, Mathes EF, Frieden IJ, Shimano KA. Int J Pediatr Otorhinolaryngol; 2018 Feb 21; 105():48-51. PubMed ID: 29447818 [Abstract] [Full Text] [Related]
19. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series. Dodds M, Tollefson M, Castelo-Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S. Pediatr Dermatol; 2020 Mar 21; 37(2):272-277. PubMed ID: 31957126 [Abstract] [Full Text] [Related]
20. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study. Hammer J, Seront E, Duez S, Dupont S, Van Damme A, Schmitz S, Hoyoux C, Chopinet C, Clapuyt P, Hammer F, Vikkula M, Boon LM. Orphanet J Rare Dis; 2018 Oct 29; 13(1):191. PubMed ID: 30373605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]